Centene Profit Rises in 1Q

Dow Jones
04/28
 

By Rob Curran

 

Centene's first-quarter earnings rose and the health insurer boosted its profit projections for the year as cost cuts and steady premium revenue growth offset rising medical expenses.

The St. Louis managed-care company posted earnings of $1.54 billion, or $3.11 a share, up from $1.31 billion, or $2.63 a share, a year earlier.

Stripping out certain one-time items, Centene logged adjusted earnings of $3.37 a share. Analysts polled by FactSet had anticipated adjusted earnings of $2.23 a share.

Revenue rose 7.1% to $49.94 billion, handily topping the Wall Street target of $47.53 billion, as tallied by FactSet.

Premium and service revenue rose 5.1% to $44.66 billion.

Centene's health-benefits ratio, a measure of how much was paid out to cover enrollees' medical expenses, was 87.3%, below the mean analyst estimate of 89.1%. Health insurers have been dogged by concerns of rising medical costs in recent quarters as an aging U.S. population avails of hospital and outpatient services at a growing pace.

"We continue to make tangible progress in our margin recovery efforts while strengthening the fundamental operations of each of our businesses," said Chief Executive Sarah London in a statement.

The company boosted its projection for 2026 per-share earnings to more than $2.37 from the previous $1.98 or higher. Centene also ratcheted up its forecast for adjusted earnings to greater than $3.40 a share from a prior estimate of more than $3 a share.

Centene boosted its 2026 revenue target, and now anticipates a range between $187.5 billion and $191.5 billion from a prior estimate of $186.5 billion to $190.5 billion, and compared with the analyst target of $188.8 billion. The company anticipates a health-benefits ratio between 90.9% and 91.7% for the year, in line with analysts' expectations of 91.4%.

Shares were up 2.3% to $44.50 in premarket trading.

 

Write to Rob Curran at rob.curran@dowjones.com

 

(END) Dow Jones Newswires

April 28, 2026 07:06 ET (11:06 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10